Movatterモバイル変換


[0]ホーム

URL:


PE20081795A1 - HTRA1-PDZ AND HTRA3-PDZ MODULATORS - Google Patents

HTRA1-PDZ AND HTRA3-PDZ MODULATORS

Info

Publication number
PE20081795A1
PE20081795A1PE2008000341APE2008000341APE20081795A1PE 20081795 A1PE20081795 A1PE 20081795A1PE 2008000341 APE2008000341 APE 2008000341APE 2008000341 APE2008000341 APE 2008000341APE 20081795 A1PE20081795 A1PE 20081795A1
Authority
PE
Peru
Prior art keywords
pdz
htra3
htra1
sequence
polypeptide
Prior art date
Application number
PE2008000341A
Other languages
Spanish (es)
Inventor
Brent A Appleton
Steven T Runyon
Sachdev S Sidhu
Nicholas J Skelton
Christian Wiesmann
Yingnan Zhang
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech IncfiledCriticalGenentech Inc
Publication of PE20081795A1publicationCriticalpatent/PE20081795A1/en

Links

Classifications

Landscapes

Abstract

Translated fromSpanish

SE REFIERE A UN POLIPEPTIDO QUE SE UNE A UN DOMINIO PDZ DE HtrA1 QUE COMPRENDE LA SECUENCIA DIETWLL (IDENTIFICADOR DE SECUENCIA Nº 3), GWKTWIL (IDENTIFICADOR DE SECUENCIA Nº 4), DSRIWWV (IDENTIFICADOR DE SECUENCIA Nº 5) O WDKIWHV (IDENTIFICADOR DE SECUENCIA Nº 6). DONDE DICHO POLIPEPTIDO COMPRENDE UNA SECUENCIA CON UNA LEUCINA O VALINA EN LA POSICION 0; UN TRIPTOFANO, ISOLEUCINA O FENILALANINA EN LA POSICION 1; UNA TREONINA O ISOLEUCINA EN LA POSICION 3; Y ACIDO GLUTAMICO, LISINA, ARGININA O ACIDO ASPARTICO EN LA POSICION 4. SE REFIERE TAMBIEN A UN POLIPEPTIDO QUE SE UNE A UN DOMINIO PDZ DE HtrA3 Y A UN METODO PARA IDENTIFICAR UN COMPUESTO CON CAPACIDAD PARA MODULAR LA INTERACCION ENTRE UN LIGANDO Y UN DOMINIO PDZ DE HtrA1 O UN DOMINIO PDZ DE HtrA3REFERS TO A POLYPEPTIDE JOINING A PDZ DOMAIN OF HtrA1 THAT INCLUDES THE SEQUENCE DIETWLL (SEQUENCE IDENTIFIER # 3), GWKTWIL (SEQUENCE IDENTIFIER # 4), DSRIWWV (SEQUENCE IDENTIFIER # 5) OR WDKIWHV No. 6). WHERE SAID POLYPEPTIDE INCLUDES A SEQUENCE WITH A LEUCINE OR VALINE IN THE 0 POSITION; A TRYPTOPHAN, ISOLEUCIN OR PHENYLALANINE IN POSITION 1; A THREONINE OR ISOLEUCINE IN POSITION 3; AND GLUTAMIC ACID, LYSINE, ARGININE OR ASPARTIC ACID IN POSITION 4. ALSO REFERS TO A POLYPEPTIDE THAT IS JOINED TO A PDZ DOMAIN OF HtrA3 AND TO A METHOD TO IDENTIFY A COMPOUND WITH CAPACITY TO MODULATE THE INTERACTION BETWEEN A LIG PD DOMAIN FROM HtrA1 OR A PDZ DOMAIN FROM HtrA3

PE2008000341A2007-02-162008-02-15 HTRA1-PDZ AND HTRA3-PDZ MODULATORSPE20081795A1 (en)

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
US89042807P2007-02-162007-02-16

Publications (1)

Publication NumberPublication Date
PE20081795A1true PE20081795A1 (en)2009-01-08

Family

ID=39590928

Family Applications (1)

Application NumberTitlePriority DateFiling Date
PE2008000341APE20081795A1 (en)2007-02-162008-02-15 HTRA1-PDZ AND HTRA3-PDZ MODULATORS

Country Status (6)

CountryLink
EP (1)EP2111413A2 (en)
AR (1)AR065370A1 (en)
CL (1)CL2008000493A1 (en)
PE (1)PE20081795A1 (en)
TW (1)TW200846358A (en)
WO (1)WO2008101160A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
ES2397441T5 (en)2006-02-132022-09-14Daiichi Sankyo Co Ltd Polynucleotide and polypeptide sequences involved in the bone remodeling process
US8168181B2 (en)2006-02-132012-05-01Alethia Biotherapeutics, Inc.Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
HRP20181457T1 (en)2011-10-142018-11-16F. Hoffmann - La Roche Ag ANTI-HTRA1 ANTIBODIES AND USE PROCEDURES
EA201590247A1 (en)2012-07-192015-10-30Алетиа Байотерапьютикс Инк. ANTIBODIES TO SIGLEC-15
DK3368578T3 (en)2015-10-302021-05-25Hoffmann La Roche Anti-HtrA1 Antibodies and Methods of Using Them
CN108699105A (en)*2016-03-042018-10-23豪夫迈·罗氏有限公司Novel difluoro keto acyl amine derivative as HTRA1 inhibitor
WO2017148964A1 (en)2016-03-042017-09-08F. Hoffmann-La Roche AgNew trifluoromethylpropanamide derivatives as htra1 inhibitors
CN109415330A (en)2016-07-182019-03-01豪夫迈·罗氏有限公司Novel difluoro keto acyl amine derivative as HTRA1 inhibitor
WO2018036957A1 (en)2016-08-232018-03-01F. Hoffmann-La Roche AgNew trifluoromethylpropanamide derivatives as htra1 inhibitors
WO2018036942A1 (en)2016-08-232018-03-01F. Hoffmann-La Roche AgNew difluoroketamide derivatives as htra1 inhibitors
WO2018206816A1 (en)*2017-05-122018-11-15Universität Duisburg-EssenTailored cyclodepsipeptides as potent non-covalent serine protease inhibitors
WO2020083916A1 (en)*2018-10-222020-04-30University Of CopenhagenVirally expressed inhibitors of pdz domains, such as pick1 and uses thereof
WO2021176094A1 (en)*2020-03-062021-09-10University Of CopenhagenLipid conjugated peptide inhibitors of pick1
CN120591277A (en)*2025-08-082025-09-05山东省农业科学院家禽研究所(山东省无特定病原鸡研究中心)Biological material for regulating HTRA1 gene expression and application thereof in antiviral

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US20090087878A9 (en)*1999-05-062009-04-02La Rosa Thomas JNucleic acid molecules associated with plants

Also Published As

Publication numberPublication date
CL2008000493A1 (en)2008-06-27
TW200846358A (en)2008-12-01
WO2008101160A3 (en)2009-02-19
WO2008101160A2 (en)2008-08-21
AR065370A1 (en)2009-06-03
EP2111413A2 (en)2009-10-28

Similar Documents

PublicationPublication DateTitle
PE20081795A1 (en) HTRA1-PDZ AND HTRA3-PDZ MODULATORS
TW200509899A (en)Amino acid composition and supplemental solution
PE20141546A1 (en) ANTI-CD134 (OX40) ANTIBODIES AND THEIR USES OF THEM
PE20140593A1 (en) POWERFUL AND SELECTIVE INHIBITORS OF NAV1.3 AND NAV1.7
AR070590A1 (en) DENTAL CLEANER
CL2008002539A1 (en) Substituted indole derivative compounds; pharmaceutical composition comprising them; and its use for the treatment of a viral infection
CL2008002538A1 (en) Substituted indole derivative compounds; pharmaceutical composition comprising them; and its use for the treatment of a viral infection
PE20141151A1 (en) CD27L ANTIGEN BINDING PROTEINS
MX2016005293A (en) PROSTACICLINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE OF THE SAME.
CL2013000083A1 (en) Compounds derived from condensed pyrimidines and triazines; procedure to prepare them; medicine that understands them; treatment and / or prevention procedure; and its use for the treatment and / or prevention of heart failure, angina pectoris, hypertension, pulmonary hypertension and ischemia, among other diseases.
CO6321207A2 (en) DENTAL THREAD INCORPORATING AN AMINO ACID
BR0103365A (en) Drive system
CO6290629A2 (en) BASIC ACID AMINO CLEANING COMPOSITIONS AND METHODS
CO5720212A1 (en) HER2 ANTIBODY COMPOSITION
EA200701097A1 (en) RECOMBINANT VECTORS OF THE INFLUENZA VIRUS WITH TANDEM TRANSCRIPTION UNITS
PE20171512A1 (en) ANTI-FAP ANTIBODIES
PE20140221A1 (en) ANTIGEN BINDING PROTEINS AGAINST PROPROTEIN CONVERSTASE SUBTILISIN / KEXIN TYPE 9 (PCSK9)
PE20100054A1 (en) DUAL VARIABLE DOMAIN IMMUNOGLOBULIN
NZ598579A (en)Oxytocin receptor agonists
RU2009142300A (en) DISPLAY ELEMENT FOR ATTACHING ADVERTISEMENT TO THE PURCHASE HANDLE
EP1374863A4 (en) AMINO ACID COMPOSITIONS USED TO IMPROVE HEPATIC INSUFFICIENCY
PE20140190A1 (en) NOTUM PROTEIN MODULATORS AND METHODS OF USE
MX2025008905A (en)Mechanical connection interface
CA2338533A1 (en)Method of treating an autoimmune disorder
ES2487637T3 (en) PDZ Modulators Disheveled

Legal Events

DateCodeTitleDescription
FAAbandonment or withdrawal

[8]ページ先頭

©2009-2025 Movatter.jp